Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Language
Publication year range
1.
Allergol. immunopatol ; 46(2): 196-200, mar.-abr. 2018. tab
Article in English | IBECS | ID: ibc-172180

ABSTRACT

Introduction: Asthma is a chronic inflammatory disease of airways with a high prevalence among children in pre-school ages. Considering controversial results in different studies about the effect of this disease on the indices of dental caries, the aim of this study was to compare dmft (decay, missing, filling teeth) situation in asthmatic and non-asthmatic 6-12-year-old children. Methods: This was a case-control study on 46 asthmatic and 47 non-asthmatic children aged 6-12 years. In asthmatic children, the severity of disease, type and dose of the administered inhalational drug, duration of drug consumption, times and technique of drug administration, and washing the mouth after drug consumption was assessed. The index of primary teeth decay or dmft, dental plaque and gingival inflammation were recorded in both groups. Data were analysed by SPSS (ver. 22) using Student's T-test, chi-square test and linear regression. Findings: dmft in case and control groups was 5.25 ± 2.25 and 4.15 ± 3.27, respectively and the difference was not statistically significant (P = 0.062). None of the variables related to asthma affected dmft (P > 0.05). Conclusion: Suffering from asthma does not affect the risk of decay in primary teeth (AU)


No disponible


Subject(s)
Humans , Male , Female , Child , Dental Caries/etiology , Asthma/drug therapy , Anti-Asthmatic Agents/administration & dosage , Administration, Inhalation , DMF Index , Risk Factors , Case-Control Studies
2.
Allergol. immunopatol ; 44(4): 322-330, jul.-ago. 2016. graf, tab
Article in English | IBECS | ID: ibc-154434

ABSTRACT

PURPOSE: The aim was to describe the clinical manifestations, complications and long-term outcome of a cohort of Iranian patients with primary immune deficiency (PID). METHOD: We retrospectively studied the demographic, clinical and immunological characteristics of the PID patients in a single tertiary centre, from January 1989 to July 2014. The patients were classified according to the International Union of Immunological Societies Expert Committee on PID. RESULTS: 98 patients were diagnosed with and followed-up for 15 disorders. The mean age at onset and diagnosis and the diagnostic delay were 8±10, 14.2±13.1 and 6.1±7 years, respectively. Parental consanguinity rate was 57%. Predominantly Antibody Deficiency was the most common diagnosis (n=63), followed by congenital defects of phagocytes (n=16), combined immunodeficiencies (n=12), well defined syndromes (n=4) and defects in innate immunity (n=3). Recurrent sinopulmonary infection was the most common presentation. Active infections were treated appropriately, in addition to prophylactic therapy with IVIG and antimicrobials. Not all the patients were compliant with prophylactic regimens due to cost and unavailability. One SCID patient underwent successful bone marrow transplantation. The total mortality rate was 19% during the follow-up period (7.8±7.6 years). The mean age of living patients at the time of study was 23±11.7 years. CONCLUSIONS: Physicians awareness of PID has been rising dramatically in Iran, ensuring an increasing number of patients being diagnosed and treated. More effective treatment services, including health insurance coverage and drug availability are needed to improve the outcome of PID patients


No disponible


Subject(s)
Humans , Male , Female , Child , Adolescent , Adult , Immunologic Deficiency Syndromes/diagnosis , Immunologic Deficiency Syndromes/immunology , Immunologic Deficiency Syndromes/pathology , Immunologic Surveillance , Immunologic Surveillance/immunology , Monitoring, Immunologic/instrumentation , Monitoring, Immunologic/methods , Desensitization, Immunologic , Laboratory Test/methods , Immunoglobulin G/analysis , Immunoglobulin G/immunology , Cohort Studies , Immunocompetence/immunology
3.
Allergol. immunopatol ; 42(5): 465-471, sept.-oct. 2014. graf, tab
Article in English | IBECS | ID: ibc-127282

ABSTRACT

BACKGROUND: This study was performed to investigate the serum level of interleukin (IL)-13, IL-4, and interferon (IFN)-γ in chronic rhinosinusitis with nasal polyps (CRSwNP) and subsequent inflammation pattern and comorbidities including asthma and aspirin intolerance. METHODS: A case-control study was conducted on 60 adult patients with CRSwNP with mean age of 37.7 ± 12.7 (ranging from 18 to 70) years, and on 20 healthy controls. Serum levels of IL-13, IL-4, and IFN-γ were assessed, using enzyme-linked immunosorbent assay to be compared between case and control groups. Serum level of total immunoglobulin (Ig) E was also assessed in the patients with CRSwNP. RESULTS: Serum level of IL-13 in the patients with CRSwNP was significantly higher than the controls (0.98 ± 1.56 vs. 0.34 ± 0.16 pg/ml, respectively, p = 0.002). IL-4 and IFN-γ did not differ significantly between the two groups. Total IgE level was significantly increased in the patients with CRSwNP, compared to the normal values (301.43 ± 516.54 IU/ml, p = 0.033). Among the patients with CRSwNP, 12/60 (20%) had aspirin intolerance and 44/60 (73.3%) had asthma. IgE was also higher in asthmatics than non-asthmatics patients (364.9 ± 586.6 vs. 126.7 ± 135.7, respectively, p = 0.015). Patients with aspirin intolerance had higher levels of IFN-γ (4.7 ± 1.4 vs. 4.1 ± 0.6, respectively, p = 0.022). CONCLUSIONS: IL-13 with high level of total IgE was observed in the patients with CRSwNP, which predisposes them to have concomitant asthma. IFN-γ seems to be down-regulated in the patients with CRSwNP, but could be over-expressed in the presence of aspirin intolerance


No disponible


Subject(s)
Humans , Male , Female , Young Adult , Adult , Middle Aged , Aged , Sinusitis/diagnosis , Sinusitis/immunology , Nasal Polyps/immunology , Nasal Polyps/physiopathology , Asthma/immunology , Interleukins , Interleukins/immunology , Immunoglobulin E/immunology , Case-Control Studies , Lung Volume Measurements , Blood Chemical Analysis/trends
4.
Monaldi Arch Chest Dis ; 65(2): 69-74, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16913576

ABSTRACT

BACKGROUND: Primary hypogammaglobulinemia disorders are a group of heterogeneous immunodeficiency syndromes with an increased susceptibility to pulmonary complications. METHODS: The aim of this study was to evaluate the extent of lung abnormalities in primary hypogammaglobulinaemic patients by high resolution computed tomography (HRCT) scan and pulmonary function test (PFT). HRCT and PFT were performed in 22 Iranian patients with primary hypogammaglobulinemia. RESULTS: Pathological bronchial findings were observed in thirteen patients: three patients showed only peribronchial thickening and the remaining ten patients suffered from both bronchiectasis and peribronchial wall thickening. Mild type of bronchiectasis and peribronchial wall thickening were the most common type, predominantly observed in the right middle and both right and left lower lobe segments of lungs. Although bullae were not found, emphysema, air-trapping, and collapse/consolidation were observed in two patients. Bronchial involvement was mostly limited to 1 up to 5 bronchopulmonary segments; only one HRCT indicated bronchial involvement in more than nine bronchopulmonary segments. Pathological bronchial findings mostly observed in the proximal bronchi; meanwhile the involvement of the distal bronchi was less common. Decreasing FEVI and FVC were observed in 65% and 55% of patients, respectively. There was a significant correlation between the HRCT score and the predicted values by PFT. The delay of diagnosis in patients with bronchiectasis was significantly higher than those without bronchiectasis. CONCLUSIONS: It seems that the majority of hypogammaglobulinaemic patients suffer from the mild type of bronchiectasis, which is mostly observed in the proximal bronchi of the lower lobe segments. The delay of diagnosis plays an important role in the occurrence of this complication in these patients.


Subject(s)
Agammaglobulinemia/complications , Bronchiectasis/etiology , Lung/pathology , Lung/physiopathology , Respiratory Function Tests , Tomography, X-Ray Computed , Adolescent , Agammaglobulinemia/diagnostic imaging , Agammaglobulinemia/pathology , Agammaglobulinemia/physiopathology , Bronchiectasis/diagnostic imaging , Bronchiectasis/pathology , Bronchiectasis/physiopathology , Case-Control Studies , Female , Humans , Lung/diagnostic imaging , Male , Regression Analysis , Respiratory Function Tests/methods , Severity of Illness Index , Tomography, X-Ray Computed/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...